Biomica Announces Closing Of $20 Million Financing Round Led By Shanghai Healthcare Capital
Amount Raised
$20 Million
Round Type
Funding Round
IsraelBiotechnologyTherapeuticsBiopharmaInvestors
Description
Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), today announced that it has closed a financing round of $20 million. The round was led by a $10 million investment from Shanghai Healthcare Capital (SHC), a leading Chinese private equity fund based in Shanghai, focused on biotech and healthcare investments globally. Following the investment, SHC holds 20% of the share capital in Biomica on a fully-diluted basis
Quick answer
Biomica raised $20 Million in a Funding Round round, dated April 27, 2023. Investors: Evogene, Shanghai Healthcare Capital and Shc. Biomica is based in Israel.
- How much did Biomica raise?
- Biomica raised $20 Million in a Funding Round round on April 27, 2023.
- Who invested in Biomica?
- Evogene, Shanghai Healthcare Capital and Shc are named as investors in this round.
- What does Biomica do?
- Biomica is an emerging biopharmaceutical company developing innovative microbiome-based therapeutics utilizing Evogene's Computational Predictive Biology (CPB) platform.
- Where is Biomica based and how big is it?
- Biomica is based in Israel.
- Who are the decision-makers at Biomica?
- Fundz holds 1 contact at Biomica, including the Chief Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biopharma around the same time
Companies in the same sectors as Biomica that raised within 45 days of this round, from Fundz verified event records.
- Alkeus Pharmaceuticals raised $150M (Series B) on June 5, 2023.
- Renibus Therapeutics raised $64M on May 25, 2023.
- OnKure Therapeutics raised $54M (Series C) on May 23, 2023.
- Decoy Therapeutics Inc. raised $6M on May 11, 2023.
- HCW Biologics raised $26M (Debt Financing) on April 27, 2023.
- Mezzion Pharma raised $40M (Funding Round) on April 25, 2023.
Who to call at Biomica, and when
A new round usually means Biomica is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Biomica raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Biomica, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Biomica. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Biomica raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Biomica raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.